Trader’s Watch List: Professional Diversity Network LLC (NASDAQ:IPDN), CorMedix, Inc. (NYSEMKT:CRMD), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), OXiGENE, Inc. (NASDAQ:OXGN), PerkinElmer Inc. (NYSE:PKI)

Professional Diversity Network LLC (NASDAQ:IPDN) belongs to Technology sector. Its net profit margin is -24.60% and weekly performance is -7.06%. On last trading day company shares ended up $2.50. Professional Diversity Network LLC (NASDAQ:IPDN) distance from 50-day simple moving average (SMA50) is -33.89%. Zacks lowered shares of Professional Diversity Network (NASDAQ:IPDN) from a hold rating to a sell rating in a research report released on Wednesday morning.

CorMedix, Inc. (NYSEMKT:CRMD) shares advanced 4.67% in last trading session and ended the day at $6.05. CRMD Gross Margin is -100.00% and its return on assets is -122.70%. CorMedix, Inc. (NYSEMKT:CRMD) quarterly performance is 16.35%. On 19 May, it was reported CorMedix Inc. (NYSEMKT:CRMD) announced that it has now received written copies of the May 8, 2015 decisions of the District Court of Mannheim on CorMedix’s patent and utility model infringement cases in Germany related to Neutrolin®. CorMedix previously announced the decisions of the Court on its investor conference call on May 8, 2015.

On 27 May, Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) shares decreased -1.38% and was closed at $2.15. BOTA EPS growth in last 5 year was 33.30%. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) year to date (YTD) performance is -4.02%.

OXiGENE, Inc. (NASDAQ:OXGN) ended the last trading day at $1.41. Company weekly volatility is calculated as 9.46% and price to cash ratio as 1.05. OXiGENE, Inc. (NASDAQ:OXGN) showed a weekly performance of 1.44%. OXiGENE, Inc. (NASDAQ:OXGN) year to date (YTD) performance is -14.29%. OXiGENE, Inc. (NASDAQ:OXGN) announced that the U.S. Patent and Trademark Office has granted it a patent (U.S. Patent No. 9,040,500) related to the use of OXi4503 for the treatment of myeloid neoplasms, including acute myeloid leukemia (AML).

PerkinElmer Inc. (NYSE:PKI) shares advanced 1.37% in last trading session and ended the day at $53.46. PKI Gross Margin is 45.00% and its return on assets is 4.10%. PerkinElmer Inc. (NYSE:PKI) quarterly performance is 14.00%. PerkinElmer, Inc. (NYSE: PKI), announced that the Company will present at the Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2015 at 8:00am PT at the Terranea Resort in Rancho Palos Verdes, California.

Leave a Reply

Your email address will not be published. Required fields are marked *